AstraZeneca PLC
AZN · NASDAQ
9/30/2025 | 6/30/2025 | 3/30/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $239,915,715 | $216,628,000 | $227,850,000 | $203,112,000 |
| - Cash | $8,143,000 | $7,058,000 | $5,230,000 | $5,488,000 |
| + Debt | $32,661,000 | $32,839,000 | $31,717,000 | $30,114,000 |
| Enterprise Value | $264,433,715 | $242,409,000 | $254,337,000 | $227,738,000 |
| Revenue | $15,191,000 | $14,457,000 | $13,588,000 | $14,891,000 |
| % Growth | 5.1% | 6.4% | -8.8% | – |
| Gross Profit | $12,329,000 | $11,984,000 | $11,347,000 | $12,166,000 |
| % Margin | 81.2% | 82.9% | 83.5% | 81.7% |
| EBITDA | $5,142,000 | $4,955,000 | $5,035,000 | $2,809,000 |
| % Margin | 33.8% | 34.3% | 37.1% | 18.9% |
| Net Income | $2,533,000 | $2,450,000 | $2,916,000 | $1,500,000 |
| % Margin | 16.7% | 16.9% | 21.5% | 10.1% |
| EPS Diluted | 0.81 | 0.79 | 0.94 | 0.48 |
| % Growth | 2.5% | -16% | 95.8% | – |
| Operating Cash Flow | $5,134,000 | $3,386,000 | $3,713,000 | $2,907,000 |
| Capital Expenditures | -$686,000 | -$1,923,000 | -$429,000 | -$955,000 |
| Free Cash Flow | $4,448,000 | $1,463,000 | $3,284,000 | $1,952,000 |